Selection and characterization of RNA aptamers to the RNA-dependent RNA polymerase from foot-and-mouth disease virus

RNA

Volumn 12, Issue 11, 2006, Pages 1970-1979

  Ellingham, Mark ^a   Bunka, David H J ^a   Rowlands, David J ^a   Stonehouse, Nicola J ^a  

^a UNIVERSITY OF LEEDS   (United Kingdom)

Author keywords

Aptamer; FMDV; In vitro selection; RNA polymerase; SELEX

Indexed keywords

APTAMER; RNA; RNA DIRECTED RNA POLYMERASE;

ARTICLE; ENZYME ACTIVITY; ENZYME INHIBITION; FOOT AND MOUTH DISEASE; IC 50; IN VITRO STUDY; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN INTERACTION; RNA REPLICATION; VIRUS GENOME;

APTAMERS, NUCLEOTIDE; BASE SEQUENCE; FOOT-AND-MOUTH DISEASE VIRUS; KINETICS; MOLECULAR SEQUENCE DATA; RNA REPLICASE; SEQUENCE ANALYSIS, DNA;

FOOT-AND-MOUTH DISEASE VIRUS;

EID: 33751078601     PISSN: 13558382     EISSN: 14699001     Source Type: Journal    
DOI: 10.1261/rna.161006     Document Type: Article

References (46)

1. Bae, S.-J., Oum, J.-H., Sharma, S., Park, J., and Lee, S.-W. 2002. In vitro selection of specific RNA inhibitors of NFATc. Biochem. Biophys. Res. Commun. 298: 486-492.
2. Belsham, G.J. and Brangwyn, J.K. 1990. A region of the 5′ noncoding region of foot-and-mouth disease virus RNA directs efficient internal initiation of protein synthesis within cells: Involvement with the role of L protease in translational control. J. Virol. 64: 5389-5395.
3. Biroccio, A., Hamm, J., Incitti, I., De Francesco, R., and Tomei, L. 2002. Selection of RNA aptamers that are specific and high-affinity ligands of the hepatitis C virus RNA-dependent RNA polymerase. J. Virol. 76: 3688-3696.
4. Blank, M. and Blind, M. 2005. Aptamers as tools for target validation. Curr. Opin. Chem. Biol. 9: 336.
5. Brody, E.N., Willis, M.C., Smith, J.D., Jayasena, S., Zichi, D., and Gold, L. 1999. The use of aptamers in large arrays for molecular diagnostics. Mol. Diagn. 4: 381-388.
6. Brooksby, J.T. 1982. Portraits of viruses: Foot-and-mouth disease virus. Intervirology 18: 1-23.
7. Bunka, D.H.J. and Stockley, P.G. 2006. Aptamers come of age - at last!. Nat. Rev. Microbiol. 44: 589-596.
8. Clarke, B.E., Brown, A.L., Currey, K.M., Newton, S.E., Rowlands, D.J., and Carroll, A.R. 1987. Potential secondary and tertiary structure in the genomic RNA of foot and mouth disease virus. Nucleic Acids Res. 15: 7067-7079.
9. Collett, J.R., Cho, E.J., and Ellington, A.D. 2005. Production and processing of aptamer microarrays. Methods 37: 4-15.
10. Convery, M.A., Stonehouse, N.J., Rowsell, S., Ellington, A.D., Hirao, I., Adams, C.J., Peabody, D.S., Phillips, S.E.V., and Stockley, P.G. 1998. Crystal structure of an RNA-aptamer complex at 2.8A resolution. Nat. Struct. Biol. 5: 133-139.
11. Cox, J.C. and Ellington, A.D. 2001. Automated selection of antiprotein aptamers. Bioorg. Med. Chem. 9: 2525-2531.
12. Cox, J.C., Rudolph, P., and Ellington, A.D. 1998. Automated RNA selection. Biotechnol. Prog. 14: 845-850.
13. Ellington, A.D. and Szostak, J.W. 1990. In vitro selection of RNA molecules that bind specific ligands. Nature 346: 818-822.
14. Ferrer-Orta, C., Arias, A., Perez-Luque, R., Escarmis, C., Domingo, E., and Verdaguer, N. 2004. Structure of foot-and-mouth disease virus RNA-dependent RNA polymerase and its complex with a template-primer RNA. J. Biol. Chem. 279: 47212-47221.
15. Ferrer-Orta, C., Arias, A., Agudo, R., Pérez-Luque, R., Escarmís, C., Domingo, E., and Verdaguer, N. 2006. The structure of a protein primer-polymerase complex in the initiation of genome replication. EMBO J. 25: 880-888.
16. Forss, S. and Schaller, H. 1982. A tandem repeat gene in a picornavirus. Nucleic Acids Res. 12: 6587-6601.
17. Gopinath, S.C., Misono, T.S., Kawasaki, K., Mizuno, T., Imai, M., Odagiri, T., and Kumar, P.K. 2006. An RNA aptamer that distinguishes between closely related human influenza viruses and inhibits haemagglutinin-mediated membrane fusion. J. Gen. Virol. 87: 479-487.
18. Hirao, I., Spingola, M., Peabody, D., and Ellington, A.D. 1998. The limits of specificity: An experimental analysis with RNA aptamers to MS2 coat protein variants. Mol. Divers 4: 75-89.
19. Hwang, B., Cho, J.S., Yeo, H.J., Kim, J.-H., Chung, K.M., Han, K., Jang, S.K., and Lee, S.-W. 2004. Isolation of specific and high-affinity RNA aptamers against NS3 helicase domain of hepatitis C virus. RNA 10: 1277-1290.
20. King, A.M., Sangar, D.V., Harris, T.J., and Brown, F. 1980. Heterogeneity of the genome-linked protein of foot-and-mouth disease virus. J. Virol. 34: 627-634.
21. Kuhn, R., Luz, N., and Beck, E. 1990. Functional analysis of the internal translation initiation site of foot-and-mouth disease virus. J. Virol. 64: 4625-4631.
22. Lee, J.F., Hesselberth, J.R., Meyers, L.A., and Ellington, A.D. 2004. Aptamer database. Nucleic Acids Res. 32: D95-100.
23. Lee, J.H., Canny, M.D., De Erkenez, A., Krilleke, D., Ng, Y.S., Shima, D.T., Pardi, A., and Jucker, F. 2005. A therapeutic aptamer inhibits angiogenesis by specifically targeting the heparin binding domain of VEGF165. Proc. Natl. Acad. Sci. 102: 18902-18907.
24. Mason, P.W., Bezborodova, S.V., and Henry, T.M. 2002. Identification and characterization of a cis-acting replication element (cre) adjacent to the internal ribosome entry site of foot-and-mouth disease virus. J. Virol. 76: 9686-9694.
25. Mason, P.W., Grubman, M.J., and Baxt, B. 2003. Molecular basis of pathogenesis of FMDV. Virus Res. 91: 9-32.
26. Misono, T.S. and Kumar, P.K.R. 2005. Selection of RNA aptamers against human influenza virus hemagglutinin using surface plasmon resonance. Anal. Biochem. 342: 312.
27. Murray, J.B., Collier, A.K., and Arnold, J.R.P. 1994. A general purification procedure for chemically synthesized oligoribonucleotides. Anal. Biochem. 218: 177.
28. Nayak, A., Goodfellow, I.G., and Belsham, G.J. 2005. Factors required for the Uridylylation of the foot-and-mouth disease virus 3B1, 3B2, and 3B3 peptides by the RNA-dependent RNA polymerase (3Dpol) in vitro. J. Virol. 79: 7698-7706.
29. Newton, S.E., Carroll, A.R., Campbell, R.O., Clarke, B.E., and Rowlands, D.J. 1985. The sequence of foot-and-mouth disease virus RNA to the 5′ side of the poly(C) tract. Gene 40: 331-336.
30. Ng, E.W., Shima, D.T., Calias, P., Cunningham Jr., E.T., Guyer, D.R., and Adamis, A.P. 2006. Pegaptanib, a targeted anti-VEGF aptamer for ocular vascular disease. Nat. Rev. Drug Discov. 5: 123-132.
31. Nickens, D.G., Patterson, J.T., and Burke, D.H. 2003. Inhibition of HIV-1 reverse transcriptase by RNA aptamers in Escherichia coli. RNA 9: 1029-1033.
32. Nishikawa, F., Kakiuchi, N., Funaji, K., Fukuda, K., Sekiya, S., and Nishikawa, S. 2003. Inhibition of HCV NS3 protease by RNA aptamers in cells. Nucleic Acids Res. 31: 1935-1943.
33. Nishikawa, F., Funaji, K., Fukuda, K., and Nishikawa, S. 2004. In vitro selection of RNA aptamers against the HCV NS3 helicase domain. Oligonucleotides 14: 114-129.
34. O'Reilly, E.K. and Kao, C.C. 1998. Analysis of RNA-dependent RNA polymerase structure and function as guided by known polymerase structures and computer predictions of secondary structure. Virology 252: 287-303.
35. Pilipenko, E.V., Blinov, V.M., Chernov, B.K., Dmitrieva, T.M., and Agol, V.I. 1989. Conservation of the secondary structure elements of the 5′-untranslated region of cardio- and aphthovirus RNAs. Nucleic Acids Res. 17: 5701-5711.
36. Robinson, M.A., Wood, J.P.A., Capaldi, S.A., Baron, A.J., Gell, C., Smith, D.A., and Stonehouse, N.J. 2006. Affinity of molecular interactions in the bacteriophage f29 packaging motor. Nucleic Acids Res. 34: 2698-2709.
37. Rowsell, S., Stonehouse, N.J., Convery, M.A., Adams, C.J., Ellington, A.D., Hirao, I., Peabody, D.S., Stockley, P.G., and Phillips, S.E.V. 1998. Crystal structures of a series of RNA aptamers complexed to the same protein target. Nat. Struct. Mol. Biol. 5: 970.
38. Scaringe, S.A., Wincott, F.E., and Caruthers, M.H. 1998. Novel RNA synthesis method using 5′-O-silyl-2′-O-orthoester protecting groups. J. Am. Chem. Soc. 120: 11820-11821.
39. Shtatland, T., Gill, S.C., Javornik, B.E., Johansson, H.E., Singer, B.S., Uhlenbeck, O.C., Zichi, D.A., and Gold, L. 2000. Interactions of Escherichia coli RNA with bacteriophage MS2 coat protein: Genomic SELEX. Nucleic Acids Res. 28: E93.
40. Tiley, L., King, A.M., and Belsham, G.J. 2003. The foot-and-mouth disease virus cis-acting replication element (cre) can be complemented in trans within infected cells. J. Virol. 77: 2243-2246.
41. Thompson, A.A. and Peersen, O.B. 2004. Structural basis for proteolysis-dependent activation of the poliovirus RNA-dependent RNA polymerase. EMBO J. 23: 3462-3471.
42. Tuerk, C. and Gold, L. 1990. Systematic evolution of ligands by exponential enrichment: RNA ligands to bacteriophage T4 DNA polymerase. Science 249: 501-510.
43. Vo, N.V., Oh, J.-W., and Lai, M.M.C. 2003. Identification of RNA ligands that bind hepatitis C virus polymerase selectively and inhibit its RNA synthesis from the natural viral RNA templates. Virology 307: 301.
44. Yamamoto-Fujita, R. and Kumar, P.K. 2005. Aptamer-derived nucleic acid oligos: applications to develop nucleic acid chips to analyze proteins and small ligands. Anal. Chem. 77: 5460-5466.
45. Ye, X., Gorin, A., Ellington, A.D., and Patel, D.J. 1996. Deep penetration of an alpha-helix into a widened RNA major groove in the HIV-1 rev peptide-RNA aptamer complex. Nat. Struct. Biol. 3: 1026-1033.
46. Zuker, M. 2003. Mfold web server for nucleic acid folding and hybridization prediction. Nucleic Acids Res. 31: 3406-3415.